Evaluation of enhanced hygroscopicity, bifidogenicity, and anticariogenicity of enzymatically synthesized beta-galactosyl-trehalose oligosaccharides.
beta-Galactosyl-trehalose oligosaccharides (beta-GTOs) were enzymatically prepared as a mixture of 6-beta-galactosyl-trehalose (1) and 4-beta-galactosyl-trehalose (2) with a 9:1 ratio (w/w). The beta-GTO mixture showed a highly enhanced hygroscopicity as compared to those of trehalose and other sugars used. At 72 h of incubation under 90% relative humidity and room temperature, it had a large increase in weight due to its moisture absorption, which was five times larger than that of trehalose, 1.9 times larger than that of sucrose, and 1.5 times larger than that of maltotriose. It was very effective in the growth promotion of Bifidobacteria, such as Bifidobacterium longum and Bifidobacterium bifidum, which was better than the growth promotion in the cases of trehalose and galactooligosaccharide. It also showed a highly anticariogenic property; it had only 10% cell proliferation of Streptococcus sobrinus for that of the sucrose control and 60% inhibition of insoluble glucan synthesis. Its effectiveness of inhibition was two and 1.5 times better than that of trehalose and one and two times than xylitol, respectively, against cell growth and glucan synthesis. Conclusively, the functionality of the beta-GTO in terms of hygroscopicity, bifidogenicity, and anticariogenicity was considerably improved as compared to that of trehalose. It is thus suggested that the beta-GTO might be applied as an effective humectant and prebiotic substitute with enhanced noncariogenicity in food applications.
Ryu
Soo-In
SI
Department of Food and Nutrition, Brain Korea 21 Project, Yonsei University, Seoul, Korea.
Kim
Bong-Gwan
BG
Park
Myung-Soo
MS
Lee
Yoon-Bok
YB
Lee
Soo-Bok
SB
D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D001644:Bifidobacterium / Q000187:drug effects / Q000254:growth & development; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D005690:Galactose / Q000378:metabolism*; D015416:Maillard Reaction; D009844:Oligosaccharides / Q000096:biosynthesis* / Q000737:chemistry / Q000494:pharmacology*; D016986:Streptococcus sobrinus / Q000187:drug effects / Q000254:growth & development; D014199:Trehalose / Q000378:metabolism*
D016588:Anticarcinogenic Agents; D009844:Oligosaccharides; D014199:Trehalose; D005690:Galactose